Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Scilex Holding Co
Report date November 10, 2022 · Filed November 16, 2022
Jointly reported with Vickers Venture Fund VI Pte Ltd, Vickers Venture Fund VI (Plan) Pte Ltd, Chi Jeffrey
Section 16 reporting ended · disclosed 2022-11-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2027-11-10 | IndirectBy Vickers Venture Fund VI Pte Ltd | 901,000 |
Reported balance
After 2022-11-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-11-10 · Other · Disposed 5,261,840 · Balance 901,000 F1: Effective November 10, 2022, Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd (and indirectly by its managing members, Jeffrey Chi, the Issuer's Chief Executive Officer, and Christopher Ho, the Issuer's Chief Financial Officer) are no longer 10% Holders of Vickers Vantage Corp. I F2: In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company ("New Scilex Warrants") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. ("Sorrento") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i) Vickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture Fund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2027-11-10 | IndirectBy Vickeres Venture Fund VI (Plan) Pte Ltd | 99,000 |
Reported balance
After 2022-11-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-11-10 · Other · Disposed 578,160 · Balance 99,000 F1: Effective November 10, 2022, Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd (and indirectly by its managing members, Jeffrey Chi, the Issuer's Chief Executive Officer, and Christopher Ho, the Issuer's Chief Financial Officer) are no longer 10% Holders of Vickers Vantage Corp. I F2: In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company ("New Scilex Warrants") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. ("Sorrento") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i) Vickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture Fund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective November 10, 2022, Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd (and indirectly by its managing members, Jeffrey Chi, the Issuer's Chief Executive Officer, and Christopher Ho, the Issuer's Chief Financial Officer) are no longer 10% Holders of Vickers Vantage Corp. I
F2: In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company ("New Scilex Warrants") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. ("Sorrento") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i) Vickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture Fund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2022 Filed Nov 16, 2022 02:47 UTC | Scilex Holding Co VCKAU · Entity 7345 | OtherWarrants · Derivative | 578,160 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-119278 · tm2229408-1_4seq1.xml · derivative · entry 2 Vickers Venture Fund VI Pte Ltd · CIK 0001839162 · 10% owner · See footnote (1) Vickers Venture Fund VI (Plan) Pte Ltd · CIK 0001839160 · See footnote (1) Chi Jeffrey · CIK 0001839163 · See footnote (1) Ho Chris · CIK 0001838628 · See footnote (1) Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vickeres Venture Fund VI (Plan) Pte Ltd Disclosed balance after: 99,000 Underlying: Common Stock · 578,160 shares Expires 2027-11-10 F1 · kind: Effective November 10, 2022, Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd (and indirectly by its managing members, Jeffrey Chi, the Issuer's Chief Executive Officer, and Christopher Ho, the Issuer's Chief Financial Officer) are no longer 10% Holders of Vickers Vantage Corp. I F2 · kind: In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company ("New Scilex Warrants") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. ("Sorrento") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i) Vickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture Fund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants. F2 · price: In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company ("New Scilex Warrants") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. ("Sorrento") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i) Vickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture Fund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants. Read SEC document |
| November 10, 2022 Filed Nov 16, 2022 02:47 UTC | Scilex Holding Co VCKAU · Entity 7345 | OtherWarrants · Derivative | 5,261,840 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-119278 · tm2229408-1_4seq1.xml · derivative · entry 1 Vickers Venture Fund VI Pte Ltd · CIK 0001839162 · 10% owner · See footnote (1) Vickers Venture Fund VI (Plan) Pte Ltd · CIK 0001839160 · See footnote (1) Chi Jeffrey · CIK 0001839163 · See footnote (1) Ho Chris · CIK 0001838628 · See footnote (1) Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vickers Venture Fund VI Pte Ltd Disclosed balance after: 901,000 Underlying: Common Stock · 5,261,840 shares Expires 2027-11-10 F1 · kind: Effective November 10, 2022, Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd (and indirectly by its managing members, Jeffrey Chi, the Issuer's Chief Executive Officer, and Christopher Ho, the Issuer's Chief Financial Officer) are no longer 10% Holders of Vickers Vantage Corp. I F2 · kind: In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company ("New Scilex Warrants") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. ("Sorrento") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i) Vickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture Fund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants. F2 · price: In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company ("New Scilex Warrants") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. ("Sorrento") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i) Vickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture Fund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.